Dr. Jose Manuel Canabal Montalvo, MD

Dr. Canabal Montalvo practices at Baycare Medical Group, Inc. in Saint Petersburg, Florida.

Dr. Canabal Montalvo's NPI, 1972132496, was assigned on April 6, 2020. Dr. Canabal Montalvo graduated from St. George's University School of Medicine in 2020. Dr. Canabal Montalvo holds Florida license ME168291.

Dr. Canabal Montalvo's primary practice is Baycare Medical Group, Inc., at 620 10th N St, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 281-9065.

Dr. Canabal Montalvo's primary practice is Baycare Medical Group, Inc. in Saint Petersburg, Florida. Dr. Canabal Montalvo is also affiliated with Morton Plant Hospital. The medical group on file is BayCare Medical Group. Dmand AI also links Dr. Canabal Montalvo to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Canabal Montalvo practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Canabal Montalvo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Canabal Montalvo is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Canabal Montalvo's licenses on file in 2 states: Florida and New York.

CMS data shows 87 Medicare services from Dr. Canabal Montalvo across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $9,736 for them. Every service was in an office.

CMS counts 92 Medicare patients who saw Dr. Canabal Montalvo in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Canabal Montalvo's median patient age at 58, with 45% women.

In 2024, Dr. Canabal Montalvo wrote 225 Medicare Part D claims for 85 patients. 87% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $449 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Canabal Montalvo for performance year 2024, reported through an alternative payment model (APM). Dr. Canabal Montalvo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Canabal Montalvo from 7 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $122.

Dr. Canabal Montalvo graduated from St. George's University School of Medicine in 2020. Dr. Canabal Montalvo is a member of AAIM and ACP.

Dr. Canabal Montalvo is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.